カテゴリ： MarketLine, ドイツ, 企業調査

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft：企業の戦略・SWOT・財務情報

◆英語タイトル：Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3930
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：53
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft – Strategy, SWOT and Corporate Finance Report
Summary

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft (Munich Re) is a provider of multi-line reinsurance products. The group offers reinsurance products for life, health, property, aviation, cyber risks, financial lines, financial risks, agriculture, capital markets, space, and workers’ compensation. Munich Re also offers primary insurance products to individuals and businesses through ERGO Group AG under the brands, including ERGO, D.A.S, DKV, ERGO Direkt, and ERV. In addition, it offers risk solutions, underwriting, and claims management services. The group offers asset management services through MEAG MUNICH ERGO AssetManagement GmbH. Munich Re writes its reinsurance business through brokers, strategic partnerships, and collaboration with primary insurance companies. It has presence across Europe, the Americas, the Asia Pacific, Africa and the Middle East. The group is headquartered in Munich, Germany.

The group reported gross premiums written of EUR49,115 million during fiscal year ended December 2017 (FY2017), an increase of 0.5% over FY2016. Its net earned premiums was EUR47,164 million in FY2017, an increase of 0.1% over FY2016.

Scope

- Detailed information on Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft in the form of a SWOT analysis
- An in-depth view of the business model of Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft including a breakdown and examination of key business segments
- Intelligence on Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Company Overview 10
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Overview and Key Facts 10
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Overview 10
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Facts 10
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Employees 12
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Employee Biographies 13
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Major Products and Services 14
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Company History 15
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Management Statement 21
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Locations and Subsidiaries 23
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Competitors 27
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Company Analysis 28
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Business Description 28
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: SWOT Analysis 29
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: SWOT Overview 29
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Strengths 29
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Weaknesses 30
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Opportunities 30
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Threats 31
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Financial Deals Activity 32
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Financial Deals Overview 32
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Targets and Partners 34
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Top Deals 2014 – 2018YTD* 36
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Advisors 37
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Top Legal Advisors 37
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Top Financial Advisors 37
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Mergers and Acquisitions 38
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Venturing 39
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Partnership 40
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Divestments 41
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Recent Developments 42
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: News and Events Summary 42
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Business Expansion 45
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Contracts 45
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Governance 47
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Financial Deals 48
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Financial Performance 48
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Regulatory and Legal Events 49
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Research & Development 49
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Strategy and Operations 49
Appendix 51
Contact Us 51
Methodology 51
About MarketLine 52

List of Tables
Table 1: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Facts
Table 2: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Employees
Table 3: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Locations and Subsidiaries
Table 4: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Key Competitors
Table 5: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Activity by Geography (TTM*)
Table 7: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Average Deal Size - Value (US$m)
Table 9: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Targets and Partners
Table 10: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Top Deals 2014 - 2018YTD*
Table 11: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Legal Advisor Ranking by Value (US$m)
Table 12: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Financial Advisor Ranking by Value (US$m)
Table 13: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Divestments by Geography (2014 - YTD*2018)
Table 21: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: News and Events Summary
Table 22: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Business Expansion
Table 23: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Contracts
Table 24: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Governance
Table 25: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Financial Deals
Table 26: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Financial Performance
Table 27: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Regulatory and Legal Events
Table 28: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Research & Development
Table 29: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Strategy and Operations

List of Figures
Figure 1: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Activity by Geography (TTM*)
Figure 3: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Average Deal Size - Value (US$m)
Figure 5: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • AxoGen Inc (AXGN)：医療機器：M&Aディール及び事業提携情報
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Enterprise Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Enterprise Therapeutics Ltd (Enterprise Therapeutics) is a drug discovery company that offers research and development of novel therapies for the treatment of respiratory diseases. The company also identifies novel targets and compounds which reduces the mucus production. It provides therape …
  • Widex AS：企業の戦略的SWOT分析
    Widex AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Trane Inc：企業の戦略的SWOT分析
    Trane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sinochem International Corp (600500)：企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Repros Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Galecto Biotech AB：製薬・医療：M&Aディール及び事業提携情報
    Summary Galecto Biotech AB (Galecto Biotech) is a drug development company that focuses on the development of galectin modulators for the treatment of cancer, fibrosis and inflammation. The company develops activators and inhibitors of galectins. Its pipeline products include TD139 inhaled Gal -3 in …
  • Grifols SA (GRF)-製薬・医療分野：企業M&A・提携分析
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Schlumberger Limited：戦略・SWOT・企業財務分析
    Schlumberger Limited - Strategy, SWOT and Corporate Finance Report Summary Schlumberger Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Toyota Tsusho Corporation：戦略・SWOT・企業財務分析
    Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Logitech International S.A. (LOGN)：企業の財務・戦略的SWOT分析
    Logitech International S.A. (LOGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Digimarc Corp (DMRC)：企業の財務・戦略的SWOT分析
    Summary Digimarc Corp (Digimarc) is a technology company that offers develops solutions, license intellectual property and provides development services to businesses and government. The company offers products such as digimarc discover, online image safeguards and digimarc guardian. Digimarc’s Disc …
  • Bausch Health Companies Inc (VRX)：医療機器：M&Aディール及び事業提携情報
    Summary Bausch Health Companies Inc(Bausch Health) formerly known as Valeant Pharmaceuticals International Inc, develops, manufactures and markets several branded, over-the-counter (OTC) and generic drugs. The company also offers medical devices such as medical contact lenses, intraocular lenses, op …
  • Saizeriya Co., Ltd.：企業の戦略・SWOT・財務分析
    Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GSE Group：企業の戦略・SWOT・財務情報
    GSE Group - Strategy, SWOT and Corporate Finance Report Summary GSE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • AerCap Holdings NV：企業の戦略・SWOT・財務情報
    AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report Summary AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tsumura & Co.：企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Marubeni Power International Inc：電力：M&Aディール及び事業提携情報
    Summary Marubeni Power International Inc (Marubeni Power International), formerly National Power Development Inc, a subsidiary of Marubeni Corp, is an energy service provider that offers electricity generation and transmission services. The company acquires established power generation portfolios an …
  • Kadmon Corp LLC-製薬・医療分野：企業M&A・提携分析
    Summary Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phenterm …
  • STRATA Skin Sciences Inc (SSKN)：企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆